The Bank of N.T. Butterfield & Son Limited provides a range of community, commercial, and private banking services to individuals and small to medium-sized businesses. The company accepts retail and corporate checking, savings, term, and interest bearing and non-interest bearing deposits. Its lending portfolio includes residential mortgage lending, automobile lending, consumer financing, credit cards, overdraft facilities, commercial real estate lending, and commercial and industrial loans, as well as overdraft facilities to commercial and corporate customers. It also offers investment products and services; and cash and liquidity management, foreign exchange, custody administration, and settlement services. In addition, the company provides personal and property/auto insurance products; letters of credit; and cash management, payroll, remote banking, money market, advisory, brokerage, trust, estate, company management, wealth management, and fiduciary services. Further, it offers debit and credit cards; automated teller machines; and personal and business deposit, merchant acquiring, residential and commercial mortgages, and mobile and internet banking services. The company operates through offices in the Cayman Islands, Guernsey, Jersey, the United Kingdom, The Bahamas, Switzerland, Singapore, Mauritius, and Canada. It also operates in Bermuda and the Cayman Islands. The company was founded in 1784 and is headquartered in Hamilton, Bermuda.

Bank of N.T. Butterfield & Son Limited (The) Voting

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Connect Biopharma Holdings today and set a price target of $7.00. According to Ti...

H.C. Wainwright Reaffirms Their Buy Rating on Connect Biopharma Holdings (CNTB)

Bank of N.T. Butterfield & Son (($NTB)) has held its Q1 earnings call. Read on for the main highlights of the call. Bank of N.T. Butterfield & Son ...

Butterfield Delivers Robust Q1 Profits Amid Integration Costs

In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings, with a price target of $7.00...

Market Cap	$2.22B	P/E Ratio	9.00
52W High	$57.84	52W Low	$40.59
Div Yield	200.0%	Payout Ratio	32.9%
EPS Growth 3Y	N/A	52W Position	94.4%
Overall Score	67	Value Score	80
Quality Score	50	Technical Score	72

EPS Current Est	$6.32	EPS Next Est	$6.9
EPS Growth Est	+9.2%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NTB	$56.88	+1.55%	73.83K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NTB	$56.88	+1.6%	73.83K
3
4
5
6

NTB

NTB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Bank of N.T. Butterfield & Son Limited (The) Voting Data in Excel

Get Bank of N.T. Butterfield & Son Limited (The) Voting Data in Excel